Investor Relations
High-growth company with focus on becoming a single-use pure player within all main endoscopy markets.
Latest news
12
Jan. 2026
Transactions under Ambu's share buyback program
add Details
On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations.
During the program, Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR.
The following transactions have been made under the program from 5 January to 9 January 2026:
| Number of shares | Average purchase price, DKK | Transaction value, DKK | |
| Accumulated under the program after lastannouncement | 577,453 | 86.6190 | 50,018,392 |
| 2026.01.05 | 39,862 | 86.9064 | 3,464,263 |
| 2026.01.06 | 0 | 0.0000 | - |
| 2026.01.07 | 9,777 | 87.4425 | 854,925 |
| 2026.01.08 | 13,715 | 87.2301 | 1,196,361 |
| 2026.01.09 | 0 | 0.0000 | - |
| Accumulated under the program | 640,807 | 86.6625 | 55,533,941 |
After the above disclosed transactions DKK 94,466,059 remains to be repurchased. Ambu now owns 3,089,931 treasuryshares, corresponding to 1.1% of the share capital.
05
Jan. 2026
Reporting of transactions made by persons discharging managerial responsibilities (no. 8)
add Details
In accordance with its long-term incentive program ("LTIP") Ambu A/S has allocated performance share units ("PSUs") to the Executive Management and other key employees. Reference is made to the company announcement of 28 July 2023 regarding the initial grant.
Pursuant to the Market Abuse Regulation article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu A/S and/or their closely associated persons related to Ambu A/S’s shares admitted to trading and official listing on NASDAQ Copenhagen A/S.
The attached document discloses the data of the transactions made by Executive Management.
05
Jan. 2026
Transactions under Ambu's share buyback program
add Details
On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations.
During the program, Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as setout in Article 5(2)(a) in MAR.
The following transactions have been made under the program from 29 December 2025 to 02 January 2026:
| Number of shares | Average purchase price, DKK | Transaction value, DKK | |
| Accumulated under the program after last announcement | 443,384 | 86.405 | 38,310,684 |
| 2025.12.29 | 1,069 | 88.2278 | 94,315.52 |
| 2025.12.30 | 33,000 | 87.9840 | 2,903,472.00 |
| 2025.12.31 | - | - | - |
| 2026.01.01 | - | - | - |
| 026.01.02 | 100,000 | 87.0992 | 8,709,920.00 |
| Accumulated under the program | 577,453 | 86.619 | 50,018,392 |
After the above disclosed transactions DKK 99,981,608 remains to be repurchased. Ambu now owns 3,027,646 treasury shares, corresponding to 1.1% of the share capital.
Upcoming events
14
Jan. 2026
JP Morgan Healthcare Conference
add Details
Ambu presents at the JP Morgan Healthcare Conference at 8:15 PST (17:15 CET).
04
Feb. 2026
Earnings release Q1 2025/26
06
May. 2026
